RB and c-Myc Activate Expression of the E-Cadherin Gene in Epithelial Cells through Interaction with Transcription Factor AP-2

REFERENCES

• Adnane, J. P., and D. Robbins 1995. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription. Oncogene 10: 381–387.
   PubMedGoogle Scholar
• Batsché, E., M. Lipp, and C. Crémisi 1994. Transcriptional repression and activation in the same cell type of the human c-myc promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen. Oncogene 9: 2235–2243.
   PubMedGoogle Scholar
• Bauer, R., A. Imhof, A. Pscherer, H. Kopp, M. Moser, S. Seegers, M. Kerscher, M. Tainsky, F. Hofstaedter, and R. Buettner 1994. The genomic structure of the human AP-2 transcription factor. Nucleic Acids Res. 22: 1413–1420.
   PubMedGoogle Scholar
• Behrens, J., O. Löwrick, L. Klein-Hitpass, and W. Birchmeier 1991. E-cadherin promoter: functional analysis of a G-C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA 88: 11495–11499.
   PubMed Web of Science ®Google Scholar
• Behrens, J., M. M. Mareel, F. F. Van Roy, and W. Birchmeier 1989. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108: 2435–2447.
   PubMed Web of Science ®Google Scholar
• Bernards, R., S. Dessain, and R. Weinberg 1986. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47: 667–674.
   PubMed Web of Science ®Google Scholar
• Birchmeier, W., J. Behrens, M. Weidner, U. Frixen, and J. Schipper 1991. Dominant and recessive genes involved in tumor cell invasion. Curr. Opin. Cell Biol. 3: 832–840.
   PubMedGoogle Scholar
• Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250: 1149–1151.
   PubMed Web of Science ®Google Scholar
• Bosher, J. M., T. Williams, and H. C. Hurst 1995. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA 92: 744–747.
   PubMed Web of Science ®Google Scholar
• Chen, P.-L., G. J. Riley, S. Chen-Kiang, and W.-H. Lee 1996. The retinoblastoma protein interacts with and activates NF-IL6. Proc. Natl. Acad. Sci. USA 93: 465–469.
   PubMedGoogle Scholar
• Chen, P.-L., D. J. Riley, Y. Chen, and W.-H. Lee 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPα. Genes Dev. 10: 2794–2804.
   PubMedGoogle Scholar
• Downs, K. M., G. R. Martin, and M. Bishop 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3: 860–869.
   PubMed Web of Science ®Google Scholar
• Gaubatz, S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner, and M. Eilers 1995. Transcriptional activation by Myc is under negative control by the transcriptional factor AP-2. EMBO J. 14: 1508–1519.
   PubMed Web of Science ®Google Scholar
• Gazin, C., S. Dupont de Dinechin, A. Hampe, J. M. Masson, P. Martin, D. Sthelin, and F. Galibert 1984. Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO J. 3: 383–387.
   PubMed Web of Science ®Google Scholar
• Haas-Kogan, D. A., C. S. Kogan, D. Levi, P. Dazin, A. T’Ang, T. Y. Fung, and M. A. Israel 1995. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14: 461–472.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., M. Dixit, C. R. Sears, and L. Sealy 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a non- canonical DNA-binding site. Genes Dev. 8: 2441–2452.
   PubMed Web of Science ®Google Scholar
• Hann, S. R., M. W. King, C. W. Bentley, C. W. Anderson, and R. N. Eisenman 1988. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt’s lymphomas. Cell 52: 185–195.
   PubMed Web of Science ®Google Scholar
• Harlow, E., and D. Lane 1988. Antibodies: a laboratory manual 521–523Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Haupt, Y., S. Rowan, and M. Oren 1995. p53-mediated apoptosis in Hela cells can be overcome by excess pRB. Oncogene 10: 1563–1571.
   PubMed Web of Science ®Google Scholar
• Hennig, G., J. Behrens, M. Truss, S. Frisch, E. Reichmann, and W. Birchmeier 1995. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11: 475–484.
   PubMed Web of Science ®Google Scholar
• Hennig, G., O. Löwrick, W. Birchmeier, and J. Behrens 1996. Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem. 271: 595–602.
   PubMed Web of Science ®Google Scholar
• Henriksson, M., and B. Lüscher 1996. Proteins of the myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68: 109–182.
   PubMed Web of Science ®Google Scholar
• Hiebert, W. S. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13: 3384–3391.
   PubMed Web of Science ®Google Scholar
• Imagawa, M., R. Chiu, and M. Karin 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51: 251–260.
   PubMed Web of Science ®Google Scholar
• Inghirami, G., F. Grignani, L. Sternas, L. Lombardi, D. M. Knowles, and R. Dalla-Favera 1990. Down-regulation of LFA-1 adhesion receptors by c-myc oncogene in human B lymphoblastoid cells. Science 250: 682–686.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., W. Krek, W. R. Sellers, I. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351–364.
   PubMed Web of Science ®Google Scholar
• Kannan, P., R. Buettner, P. J. Chiao, S. D. Yim, M. Sarkiss, and M. A. Tainsky 1994. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 8: 1258–1269.
   PubMedGoogle Scholar
• Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. Weinberg 1986. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6: 1917–1925.
   PubMed Web of Science ®Google Scholar
• Larue, L., M. Ohsugi, J. Hirchenhain, and R. Kemler 1994. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. USA 91: 8263–8267.
   PubMed Web of Science ®Google Scholar
• Leask, A., C. Byrne, and E. Fuchs 1991. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc. Natl. Acad. Sci. USA 88: 7948–7952.
   PubMedGoogle Scholar
• Martel, C., E. Batsché, F. Harper, and C. Crémisi 1996. Inactivation of the retinoblastoma gene product or an RB-related protein by SV40 T antigen in MDCK epithelial cells results in massive apoptosis. Cell Death Differ. 3: 61–74.
   Google Scholar
• Martel, C., F. Harper, S. Cereghini, N. Veerlé, M. Mareel, and C. Crémisi 1997. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ. 8: 165–178.
   PubMedGoogle Scholar
• Martel, C., D. Lallemand, and C. Crémisi 1995. Specific c-myc and max regulation in epithelial cells. Oncogene 10: 2195–2205.
   PubMedGoogle Scholar
• Mitchell, P. J., P. M. Timmons, J. M. Hebert, P. W. Rigby, and R. Tjian 1991. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5: 105–119.
   PubMed Web of Science ®Google Scholar
• Mitchell, P. J., C. Wang, and R. Tjian 1987. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50: 847–861.
   PubMed Web of Science ®Google Scholar
• Muchardt, C., J.-S. Seeler, A. Nirula, S. Gong, and R. Gaynor 1992. Transcription factor AP-2 activates gene expression of HTLV-1. EMBO J. 11: 2573–2581.
   PubMed Web of Science ®Google Scholar
• Muchardt, C., J. S. Seeler, and R. B. Gaynor 1992. Regulation of HTLV-1 gene expression by tax and AP-2. New Biol. 4: 541–550.
   PubMedGoogle Scholar
• Mugrauer, G., and P. Ekblom 1991. Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J. Cell Biol. 112: 13–25.
   PubMed Web of Science ®Google Scholar
• Onclercq, R., A. Lavenu, and C. Crémisi 1989. Pleiotropic derepression of developmentally regulated cellular and viral genes by the product of c-myc protooncogene in undifferentiated embryonal carcinoma cells. Nucleic Acids Res. 17: 735–753.
   PubMedGoogle Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses 1990. TGFβ1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming pRB binding domains. Cell 61: 777–785.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., L. E. Diamond, D. Dahl, and M. D. Cole 1990. The c-Myc-regulated gene mr1 encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10: 1265–1269.
   PubMed Web of Science ®Google Scholar
• Qin, X.-Q., T. Chittenden, D. M. Livingston, and W. G. Kaelin 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6: 953–964.
   PubMed Web of Science ®Google Scholar
• Riethmacher, D., V. Brinkmann, and C. Birchmeier 1995. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl. Acad. Sci. USA 92: 855–859.
   PubMed Web of Science ®Google Scholar
• Ringwald, M., H. Baribault, C. Schmidt, and R. Kemler 1991. The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. Nucleic Acids Res. 19: 6533–6539.
   PubMed Web of Science ®Google Scholar
• Schmid, P., W. Schulz, and H. Hameister 1989. Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science 243: 226–229.
   PubMed Web of Science ®Google Scholar
• Smith, D. B., and K. S. Johnson 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31–40.
   PubMed Web of Science ®Google Scholar
• Snow, M. H. L. 1977. Gastrulation in the mouse: growth and regionalization of the epiblast. J. Embryol. Exp. Morphol. 42: 293–303.
   Google Scholar
• Suen, T.-C., and M.-C. Hung 1991. c-myc reverses neu-induced transformed morphology by transcriptional repression. Mol. Cell. Biol. 11: 354–362.
   PubMed Web of Science ®Google Scholar
• Szekely, L., W. Jiang, F. Bulic-Jakus, A. Rosen, N. Ringertz, G. Klein, and K. G. Wiman 1992. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ. 3: 149–156.
   PubMedGoogle Scholar
• Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association and nuclear tethering. Proc. Natl. Acad. Sci. USA 88: 3033–3037.
   PubMed Web of Science ®Google Scholar
• Thiery, J.-P., J.-L. Duband, U. Rutishauser, and G. M. Edelman 1982. Cell adhesion molecules in early chicken embryogenesis. Proc. Natl. Acad. Sci. USA 79: 6731–6741.
   Google Scholar
• Versteeg, R., A. Noordermeer, M. Krüse-Wolters, D. J. Ruiter, and P. I. Schrier 1988. c-myc down-regulates class 1 HLA expression in human melanomas. EMBO J. 7: 1023–1029.
   PubMed Web of Science ®Google Scholar
• Wang, J. Y. J., E. S. Knudsen, and P. J. Welch 1994. The retinoblastoma tumor-suppressor protein. Adv. Cancer Res. 64: 25–85.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. 1991. Tumor suppressor genes. Science 254: 1138–1146.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
   PubMed Web of Science ®Google Scholar
• Welch, P. J., and J. Y. Wang 1995. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev. 9: 31–46.
   PubMedGoogle Scholar
• Williams, T., A. Admon, B. Lüscher, and R. Tjian 1988. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2: 1557–1569.
   PubMed Web of Science ®Google Scholar
• Yang, B.-S., T. J. Geddes, R. J. Pogulis, B. de Crombrugghe, and S. O. Freytag 1991. Transcriptional suppression of cellular gene expression by c-Myc. Mol. Cell. Biol. 11: 2291–2295.
   PubMed Web of Science ®Google Scholar